PAR 0.00% 21.0¢ paradigm biopharmaceuticals limited..

Paradigm patent rejection, page-26

  1. 572 Posts.
    lightbulb Created with Sketch. 55
    "Paradigm Biopharmaceuticals Ltd (ASXAR) has strengthened its board with intellectual property (IP) expertise through the appointment of Amos Meltzer as an independent non-executive director.Meltzer is a scientist and an intellectual property lawyer with more than 25 years of experience in international trade and in commercialising technologies, overwhelmingly in the life sciences.He has presided over life science research and product development projects as well as clinical trials and the sale and marketing of a pharmaceutical product.Amos’ experience and expertise is drawn from having worked in large law firms (Freehills and K&L Gates) and in house counsel and IP director at two Nasdaq-listed companies, as a non-executive director of a biotechnology company and as VP of Business Development and then CEO of an ASX-listed biopharmaceutical company."

    whoops
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
21.0¢
Change
0.000(0.00%)
Mkt cap ! $73.55M
Open High Low Value Volume
21.0¢ 22.0¢ 20.5¢ $222.5K 1.035M

Buyers (Bids)

No. Vol. Price($)
5 77810 21.0¢
 

Sellers (Offers)

Price($) Vol. No.
22.0¢ 23000 2
View Market Depth
Last trade - 16.10pm 11/10/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.